You are here

leukemia

OCI-led CAR-T leukemia therapy receives €2.5m from EIC

OCI-led CAR-T leukemia therapy receives €2.5m from EIC

Pharmaphorum

Flag link:

Days after halting leukemia drug, Magenta moves to close its doors

Days after halting leukemia drug, Magenta moves to close its doors

Fierce Biotech

Magenta Therapeutics

Flag link:

AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market

AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market

MPR

Flag link:

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA

Rigel bets $230M that Forma's leukemia drug gets in formation with FDA

Fierce Biotech

Rigel Pharmaceuticals

Forma Therapeutics

Flag link:

Teva recalls one lot of leukemia med after finding particulates in vial

Teva recalls one lot of leukemia med after finding particulates in vial

Fierce Pharma

Teva Pharmaceutical

product recalls

Flag link:

ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again

ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again

Fierce Biotech

clinical trials

Flag link:

AskBio, Syndax and Catalyst All on the Fast Track

AskBio, Syndax and Catalyst All on the Fast Track

BioSpace

fast track status

Catalyst Biosciences

episodic bleeding

Flag link:

Syndax looks to rebound from stinging late-stage failure, uncorking early data for next cancer drug up

Syndax looks to rebound from stinging late-stage failure, uncorking early data for next cancer drug up

Endpoints

clinical trials

Flag link:

Bluebird stops studies of sickle cell gene therapy after new cancer cases

Bluebird stops studies of sickle cell gene therapy after new cancer cases

BioPharma Dive

sickle cell disease

clinical trials

Flag link:

OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment

OncoImmune nabs $56M round for late-stage COVID-19 tests, leukemia treatment

Fierce Biotech

Flag link:

Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year

Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year

MedCity News

Gilead Sciences

Flag link:

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

Fierce Biotech

Flag link:

Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable

Common Serious Side-Effect Of CAR T-Cell Therapy May Be Preventable

Forbes

cytokine release syndrome

Flag link:

3 Biotech Stocks With Major Catalysts Incoming

3 Biotech Stocks With Major Catalysts Incoming

Motley Fool

TG Therapeutics

Cara Therapeutics

rheumatoid arthritis

Flag link:

New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’

New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’

Stat

Flag link:

Two cancer drug prices have already been hiked by 8% this year

Two cancer drug prices have already been hiked by 8% this year

Marketwatch

Teva Pharmaceutical

Flag link:

Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep

Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep

Endpoints

clinical trials

Flag link:

Pfizer's leukemia drug approved by UK cost watchdog after previous rejection

Pfizer's leukemia drug approved by UK cost watchdog after previous rejection

BioPharma Dive

Flag link:

Pfizer Drug Wins U.K. Support Following Overhaul of Cancer Fund

Pfizer Drug Wins U.K. Support Following Overhaul of Cancer Fund

Bloomberg

Flag link:

Martin Shkreli's Arrest Halts Leukemia Drug Trial

Martin Shkreli's Arrest Halts Leukemia Drug Trial

Fortune

clinical trials

Flag link:

Pages